References
- Kopel E, Oren G, Sidi Y, David D. Inadequate antibody response to rabies vaccine in immunocompromised patient. Emerg Infect Dis 2012; 18:1493 - 5; http://dx.doi.org/10.3201/eid1809.111833; PMID: 22932226
- Evans JS, Horton DL, Easton AJ, Fooks AR, Banyard AC. Rabies virus vaccines: is there a need for a pan-lyssavirus vaccine?. Vaccine 2012; 30:7447 - 54; http://dx.doi.org/10.1016/j.vaccine.2012.10.015; PMID: 23084854
- Song M, Tang Q, Wang DM, Mo ZJ, Guo SH, Li H, Tao XY, Rupprecht CE, Feng ZJ, Liang GD. Epidemiological investigations of human rabies in China. BMC Infect Dis 2009; 9:210; http://dx.doi.org/10.1186/1471-2334-9-210; PMID: 20025742
- Zhu WY, Liang GD. Current status of canine rabies in China. Biomed Environ Sci 2012; 25:602 - 5; PMID: 23122320
- Liu H, Huang G, Tang Q, Li J, Cao S, Fu C, Cao Q, Liu B, Pan H, Wang M. The immunogenicity and safety of vaccination with purified Vero cell rabies vaccine (PVRV) in China under a 2-1-1 regimen. Hum Vaccin 2011; 7:220 - 4; http://dx.doi.org/10.4161/hv.7.2.14003; PMID: 21311216
- Rabies WECo. Guide for post-exposure treatment. Eighth report. WHO technical report 824. Geneva Switzerland: World Health Organization 1992.
- Warrell MJ. Current rabies vaccines and prophylaxis schedules: preventing rabies before and after exposure. Travel Med Infect Dis 2012; 10:1 - 15; http://dx.doi.org/10.1016/j.tmaid.2011.12.005; PMID: 22342356
- Malerczyk C, Vakil HB, Bender W. Rabies pre-exposure vaccination of children with purified chick embryo cell vaccine (PCECV). Hum Vaccin Immunother 2013; 9:1454 - 9; http://dx.doi.org/10.4161/hv.24502; PMID: 23571224
- Chhabra M, Ichhpujani RL, Bhardwaj M, Tiwari KN, Panda RC, Lal S. Safety and immunogenicity of the intradermal Thai red cross (2-2-2-0-1-1) post exposure vaccination regimen in the Indian population using purified chick embryo cell rabies vaccine. Indian J Med Microbiol 2005; 23:24 - 8; http://dx.doi.org/10.4103/0255-0857.13868; PMID: 15928417
- Sudarshan MK, Gangaboraiah B, Ravish HS, Narayana DH. Assessing the relationship between antigenicity and immunogenicity of human rabies vaccines when administered by intradermal route: results of a metaanalysis. Hum Vaccin 2010; 6:562 - 5; http://dx.doi.org/10.4161/hv.6.7.11934; PMID: 20523131
- Zhang X, Zhu Z, Wang C. Persistence of rabies antibody 5 years after postexposure prophylaxis with vero cell antirabies vaccine and antibody response to a single booster dose. Clin Vaccine Immunol 2011; 18:1477 - 9; http://dx.doi.org/10.1128/CVI.05090-11; PMID: 21752947